INSTRUCTIONS TO AUTHORS
About the Journal
Oxford Open Immunology is a fully open access peer-reviewed journal. All papers published in Oxford Open Immunology are made freely available online under an open access licence, with applicable charges. Please refer to the open access section below.
Once a paper is accepted, Oxford Open Immunology will publish a pre-copyedited, pre-proofed version of the paper online within 1 week. This is replaced by a copyedited, proofed version of the paper as soon as it is ready.
Please read these instructions carefully and follow them closely. The Editors may return manuscripts that do not follow these instructions.
Scope of the Journal
Oxford Open Immunology publishes high-interest research and reviews across all aspects of the immune system in health and disease. Taking a bench to bedside approach, the journal brings together the mechanistic, basic research on the biology and workings of the immune system alongside clinical perspectives and applications of cutting edge immunology-based research for diagnosis and treatment of clinical disease. Disease relevance can include autoimmunity, cancer, infectious diseases, immunodeficiencies, metabolic disease and transplantation. Oxford Open Immunology particularly encourages submissions in emerging disciplines, including immune-informatics and systems immunology, microbiota research, single-cell and NGS approaches, mass cytometry and imaging.
All submissions to the journal are initially reviewed by one of the journal editors. At this stage, manuscripts may be rejected without peer review if it is felt that they are not relevant to the journal or are not of high enough priority. This fast rejection process means that authors are given a quick decision and do not need to wait for the review process to be completed.
Manuscripts that are not instantly rejected are sent out for peer review, usually to two independent reviewers. Based on the feedback from these reviewers and the editors’ judgement, a decision is given on the manuscript. Authors will normally be notified of acceptance, rejection, or need for revision as quickly as possible.
As part of our efforts to increase transparency in the field, and to highlight the enormous contribution of peer reviewers, Oxford Open Immunology operates a rigorous and constructive optional Open Peer Review, whereby authors are given the option for the reviewer comments to be made available on publication alongside the published manuscript. Reviewers are also given the option to disclose their identities by signing their reports, meaning that on publication these reports can be anonymous, or if reviewers decide to sign their reviews, these will also include the reviewer’s name.
Visit our author resources for generic author FAQs.
Authors should observe high standards with respect to publication best practice. Falsification or fabrication of data, plagiarism, including duplicate publication of the authors’ own work without proper citation, and misappropriation of work are all unacceptable practices. Any cases of ethical or publication malpractice are treated very seriously and will be managed in accordance with the Commission on Publication Ethics (COPE) guidelines. Further information about OUP’s ethical policies is available on the Oxford ethics page.
Manuscripts submitted to Oxford Open Immunology may be screened with iThenticate anti-plagiarism software in an attempt to detect and prevent plagiarism. Any manuscript may be screened, especially if there is reason to suppose part or all of the text has been previously published. Prior to final acceptance any manuscript that has not already been screened may be put through iThenticate. More information about iThenticate can be found iThenticate page.
Consent from patients
Papers reporting experiments on patients or healthy volunteers must record the fact that the subjects' consent was obtained according to the Declaration of Helsinki. It must also be approved by the ethical committee of the institution in which the work was performed. Consent for publication must also be recorded when photographs or other images of patients are shown or other details are given that could lead to identification of these individuals.
Sex and Gender Equity in Research
We encourage our authors to follow the ‘Sex and Gender Equity in Research – SAGER – guidelines’ and to include sex and gender considerations where relevant. Authors should use the terms sex (biological attribute) and gender (shaped by social and cultural circumstances) carefully in order to avoid confusing both terms. Article titles and/or abstracts should indicate clearly what sex(es) the study applies to. Authors should also describe in the background, whether sex and/or gender differences may be expected; report how sex and/or gender were accounted for in the design of the study; provide disaggregated data by sex and/or gender, where appropriate; and discuss respective results. If a sex and/or gender analysis was not conducted, the rationale should be given in the Discussion. We suggest that our authors consult the full guidelines before submission.
The ARRIVE guidelines must be followed when preparing manuscripts for Oxford Open Immunology. Experiments with animals should be performed in accordance with the legal requirements of the relevant local or national authority and the name of the authorizing body should be stated in the paper. Procedures should be such that experimental animals do not suffer unnecessarily. The text of the paper should include experimental details of the procedure and of anaesthetics used. The journal reserves the right to reject papers where the ethical aspects are, in the Editor's opinion, open to doubt.
Availability of Data and Materials
Where ethically feasible, Oxford Open Immunology strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. Authors are required to include a Data Availability Statement in their article.
We suggest that data be presented in the main manuscript or additional supporting files, or deposited in a public repository whenever possible. Information on general repositories for all data types, and a list of recommended repositories by subject area, is available on the research data policy page.
Data Availability Statement
The inclusion of a Data Availability Statement is a requirement for articles published in Oxford Open Immunology. Data Availability Statements provide a standardised format for readers to understand the availability of data underlying the research results described in the article. The statement may refer to original data generated in the course of the study or to third-party data analysed in the article. The statement should describe and provide means of access, where possible, by linking to the data or providing the required unique identifier.
The Data Availability Statement should be included in the endmatter of your article under the heading 'Data availability'.
More information and example Data Availability Statements can be found on the research data policy page .
Oxford Open Immunology supports the Force 11 Data Citation Principles and requires that all publicly available datasets be fully referenced in the reference list with an accession number or unique identifier such as a digital object identifier (DOI). Data citations should include the minimum information recommended by DataCite: [dataset] Authors, Year, Title, Publisher (repository or archive name), Identifier. An example for Oxford Open Immunology is:
[dataset] Anderson AB, Brook CD. A dataset of examples. GitHub: doi:10.1066/FTQ0414, 2020.
The inclusion of the [dataset] tag at the beginning of the citation helps us to correctly identify and tag the citation. This tag will be removed from the citation published in the reference list.
Preprint and self-archiving policy
Authors retain the right to make an Author’s Original Version (preprint) available through various channels, and this does not prevent submission to the journal. For further information see our Online Licensing, Copyright and Permissions policies. If accepted, the authors are required to update the status of any preprint, including your published paper’s DOI, as described on our Author Self-Archiving policy page. You may self-archive versions of your work on your own webpages, on institutional webpages, and in other repositories.
Conflict of Interest
When submitting a paper, you and your co-authors must declare any potential conflicts of interest. You must do this by including a Conflict of Interest statement in your submitted manuscript.
You can find a detailed definition of conflicts of interests on the publication ethics page.
We will consider your manuscript as long as:
- it is your own original work and does not duplicate any previously published work, including your own;
- it is not under consideration, in peer review, or accepted for publication in any journal other than Oxford Open Immunology;
- it has not been published in any other journal; and
- it contains nothing abusive, defamatory, libelous, obscene, fraudulent, or illegal.
Authors should observe high ethical standards and obey publication best practices. The following are all unacceptable:
- data falsification or fabrication
- plagiarism, including duplicate publication of your own work without proper citation
- misappropriation of work
We treat any case of ethical or publication malpractice very seriously. We will address them in accordance with the Committee on Publication Ethics (COPE) guidelines. Further information about OUP's ethical policies is available on the Committee on Publication Ethics (COPE) Guidelines On Good Publication Practice page.
How to Submit
You must submit your paper via our web-based submission system, which may be found on ScholarOne Manuscripts submission site.
If you have not published with Oxford Open Immunology before, you will need to create an account. For more information about using ScholarOne, please click on the author support page. Questions about submitting to the journal should be sent to the editorial office at: email@example.com
This journal publishes several different article types.
|Abstract: word count||Abstract structure||Keywords||Word count|
|RESEARCH ARTICLE||250||Structured: Objectives, Methods, Results and Conclusion||6||8,000|
|NEW TECHNICAL APPROACHES||250||Unstructured||6||8,000|
If you wish to reproduce any material for which you do not own the copyright—including quotations, tables, or images—you must obtain permission from the copyright holder. The permissions agreement must include the following documents:
- nonexclusive rights to reproduce the material in your article in Oxford Open Immunology
- both print and electronic rights, preferably for use in any form or medium
- lifetime rights to use the material
- worldwide English-language rights
Further information on obtaining permissions is available on the permissions guidelines page.
Manuscript Preparation: Format, Structure, and Style
At first submission, it is not necessary to apply formatting to match house style. Instead, simply ask: would I enjoy reading and reviewing a manuscript formatted in this way. Manuscripts can be submitted in any common document format that can be easily opened and read by others. A single PDF or Word file is usually reliable.
After initial review, you may be asked to supply editable files that match journal formatting requirements, and high-resolution figures.
Presubmission Language Editing
If you are not confident in the quality of your English, you may wish to use a language-editing service to ensure that editors and reviewers understand your paper. Language editing is optional and does not guarantee that your manuscript will be accepted. Edited manuscripts will still undergo peer review by the journal.
Please include the following:
- the title of your paper
- all author names and affiliations
- mailing address and email address of one corresponding author
- a short running head of 50 characters or less
Please list all author contributions upon submission of the manuscript.
Please see the CASRAI CRediT taxonomy for instructions on how to declare, describe and format authorship details in the manuscript. This information is collected during the submission process.
Abstracts have a maximum length of 250 words and must not contain reference citations or abbreviations.
Authors of Research articles, Review articles, and New Technical Approaches are encouraged to submit a graphical abstract as part of the article, in addition to the text abstract. The graphical abstract should clearly summarize the focus and findings of the article, and will be published as part of the article online and in PDF. The graphical abstract should be submitted for peer review as a separate file, selecting the appropriate file-type designation in the journal’s online submission system. The file should be clearly named, e.g. graphical_abstract.tiff. See Preparing and submitting your manuscript for guidance on appropriate file format and resolution for graphics.
Authors of Review articles, Research articles and New Technical Approaches are encouraged to submit a lay summary as part of the article, in addition to the main text abstract. The lay summary should clearly summarize the focus and findings of the article for non-expert readers, and will be published as part of the article online and in PDF. The lay summary should be submitted for peer review as part of the main manuscript file, under the heading ‘Lay summary’, before the article’s main text. The lay summary should be no longer than 200 words. As with a main abstract, avoid citations and define any abbreviations.
The journal follows Oxford SCIMED style. Please refer to these requirements when preparing your manuscript after initial review. More information is available on the style guide. UK or US spelling should be used throughout, except in quotations and in references.
Please define nonstandard abbreviations at the first occurrence.
You must number all tables (e.g., table 1, table 2, table 3) and reference them in the text. You must place all tables at the end of the main text.
This journal accepts videos to be published as part of the article and/or included in the supplementary material. A submission guide can be found on the video and media guidelines page.
You may format references in any readable style at submission. You are responsible for the accuracy of reference information.
Acknowledgments and Funding
Acknowledgments and funding information should be included at the end of your manuscript. Please fully cite any relevant funding information, including specific grant numbers.
Information on LaTeX files and formatting can be found on the latex guidelines page.
You must include figure titles and legends within the manuscript file—they should not be included in the image file.
You must submit each figure as an individual image file. Submit all panels of a multipanel figure on a single page as one file. For example, if the figure has 3 panels, the figure should be submitted as one file. Each panel should be labeled as a letter (A, B, C, D, etc.) in the upper-left corner of each panel.
Images of photographs or paintings can be provided as raster images. Common examples of raster images are .tif/.tiff, .raw, .gif, and .bmp file types. The resolution of raster files is measured by the number of dots or pixels in a given area, referred to as “dpi” or “ppi.”
Minimum resolution for electronic images (i.e., for on-screen viewing): 72dpi
Images of maps, charts, graphs, and diagrams are best rendered digitally as geometric forms called vector graphics. Common file types are .eps, .ai, and .pdf. Vector images use mathematical relationships between points and the lines connecting them to describe an image. These file types do not use pixels; therefore resolution does not apply to vector images.
Figures prepared as .doc/.docx or .jpeg/.jpg files will not be accepted.
You must submit supplementary data or supplementary material at the same time as the main manuscript.
Supplementary material must be cited in the text of the main manuscript.
Supplementary material will be available online only and will not be copyedited.
Style and formatting of supplementary material should be consistent with that of the manuscript.
Supplementary material should be formatted to function on any internet browser.
Supplementary material files should be no larger than 2MB each.
Licence to Publish and Open Access Options
Oxford Open Immunology is a fully open access journal and depends upon open access publication fees for its operation. If your paper is accepted, you will be charged an open access fee: please see the charges section below. All papers are freely available online upon publication under an open access licence.
After your manuscript is accepted, you must sign a licence to publish form on our Author Services website.
Oxford Open Immunology articles can be published under the following Creative Commons licences:
Creative Commons Attribution licence (CC BY)
Your funding agencies may have specific requirements for what type of open access licence to use, so please check before selecting a licence. Please visit our Open Access page for more information about the Creative Commons licences. Please check with your funding body if you are unsure of any licence requirements. After your paper has been accepted for publication, if you require a different sort of licence for funding purposes, you can request it from the journal’s production team.
You can pay open access charges on the same Author Services site you used to sign your licence to publish. You can pay immediately online or request an invoice by email or post. You may also refer the charges to an institutional prepayment account. Any applicable discounts can also be applied prior to payment.
You can pay your open access charges immediately after you sign your licence.
OA Licence Charges
Charges for the open access licence options offered by Oxford Open Immunology are listed below.
Charges for CC BY: ￡1600/ $2150/ €1800.
Authors from qualifying developing countries are entitled to a waiver of their Open Access licence fee and can request this at acceptance. Visit our developing countries page for a list of qualifying countries and more information.